Evaluation of immune system in patients with transfusion-dependent beta-thalassemia in Rasoul-e-Akram Hospital in 2021: A descriptive cross-sectional study.

Fahime EhsanipourMohammad FaranoushMohammad Reza Foroughi-GilvaeeNegin SadighniaMorteza FallahpourMona MotamediAfsoon ZandiZahra SafaeiAshkan ZandiMohammad Faranoush

Published in: Health science reports (2022)

Iron chelator agents effectively improve patients' immune system with thalassemia major. The increase in IgG and IgM immunoglobulins levels is due to frequent blood transfusions, which stimulate the immune system.

Keyphrases

end stage renal disease
sickle cell disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
peritoneal dialysis
patient reported outcomes